Coya Therapeutics, Inc. (COYA)

NASDAQ: COYA · Real-Time Price · USD

4.120

+0.170 (4.30%)

At close: Oct 27, 2026, 4:00 PM EDT

4.120

0.00 (0.00%)

After-hours: Oct 27, 2026, 4:00 PM EDT

Coya Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	43.18	46.82	38.34	32.63	5.93	4.34
Cash & Short-Term Investments	43.18	46.82	38.34	32.63	5.93	4.34
Cash Growth	45.11%	22.13%	17.51%	449.85%	36.72%	-50.23%
Other Receivables	-	-	0.73	7.5	-	-
Receivables	-	-	0.73	7.5	-	-
Prepaid Expenses	3.88	3.12	5.24	1.07	1.25	0.24
Total Current Assets	47.06	49.94	44.31	41.2	7.18	4.58
Property, Plant & Equipment	0.01	0.01	0.04	0.07	0.09	0.12
Long-Term Deferred Charges	-	-	-	-	1.12	0.09
Total Assets	47.31	49.95	44.35	41.26	8.4	4.79

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	1.09	1.06	1.59	1.16	1.82	0.86
Accrued Expenses	1.19	3.61	1.39	2.25	2.01	0.29
Current Income Taxes Payable	-	-	-	0.72	-	-
Current Unearned Revenue	1.23	1.2	0.85	0.92	-	-
Total Current Liabilities	3.51	5.87	3.82	5.05	3.82	1.15
Long-Term Debt	-	-	-	-	12.97	-
Long-Term Unearned Revenue	0.52	1.05	0.95	0.57	-	-
Total Liabilities	4.03	6.92	4.77	5.63	16.79	1.15

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	119.08	104.99	80.31	61.5	0.68	0.47
Retained Earnings	-75.81	-61.96	-40.74	-25.86	-17.87	-5.62
Comprehensive Income & Other	-	-	-	-0.01	-	-
Total Common Equity	43.28	43.03	39.58	35.64	-17.19	-5.15
Shareholders' Equity	43.28	43.03	39.58	35.64	-8.39	3.64
Total Liabilities & Equity	47.31	49.95	44.35	41.26	8.4	4.79

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	-	-	-	-	12.97	-
Net Cash (Debt)	43.18	46.82	38.34	32.63	-7.03	4.34
Net Cash Growth	45.11%	22.13%	17.51%	-	-	-50.23%
Net Cash Per Share	2.17	2.80	2.52	3.21	-2.71	1.68
Filing Date Shares Outstanding	23.46	23.46	16.72	14.54	9.95	2.59
Total Common Shares Outstanding	23.46	20.93	16.71	14.41	2.59	2.59
Working Capital	43.55	44.07	40.48	36.14	3.36	3.44
Book Value Per Share	1.84	2.06	2.37	2.47	-6.64	-1.99
Tangible Book Value	43.28	43.03	39.58	35.64	-17.19	-5.15
Tangible Book Value Per Share	1.84	2.06	2.37	2.47	-6.64	-1.99
Machinery	-	-	-	0.14	0.14	0.14

SEC Filings: 10-K · 10-Q